BE887220A - Compositions antitumeurs - Google Patents

Compositions antitumeurs Download PDF

Info

Publication number
BE887220A
BE887220A BE0/203590A BE203590A BE887220A BE 887220 A BE887220 A BE 887220A BE 0/203590 A BE0/203590 A BE 0/203590A BE 203590 A BE203590 A BE 203590A BE 887220 A BE887220 A BE 887220A
Authority
BE
Belgium
Prior art keywords
emi
organic acid
anisidide
gluconolactone
water
Prior art date
Application number
BE0/203590A
Other languages
English (en)
French (fr)
Inventor
E Granatek
D Bouzard
J Stemer
C Perol
A Weber
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of BE887220A publication Critical patent/BE887220A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08—Nitrogen atoms
    • C07D219/10—Nitrogen atoms attached in position 9
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE0/203590A 1980-01-24 1981-01-23 Compositions antitumeurs BE887220A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11480980A 1980-01-24 1980-01-24

Publications (1)

Publication Number Publication Date
BE887220A true BE887220A (fr) 1981-07-23

Family

ID=22357561

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/203590A BE887220A (fr) 1980-01-24 1981-01-23 Compositions antitumeurs

Country Status (3)

Country Link
JP (1) JPS56150067A (fa)
BE (1) BE887220A (fa)
ZA (1) ZA81420B (fa)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA811304B (en) * 1980-03-11 1982-06-30 Warner Lambert Co Pharmaceutical salts of 4'-(9-acridinylamino)methanesulfon-m-anisidide
AU679940B2 (en) * 1992-10-27 1997-07-17 Fuso Chemical Co., Ltd. Bifidobacterium growth promoter

Also Published As

Publication number Publication date
JPS56150067A (en) 1981-11-20
JPH032862B2 (fa) 1991-01-17
ZA81420B (en) 1982-02-24

Similar Documents

Publication Publication Date Title
EP0078785B1 (fr) Sels d'acide valproîque, leur préparation et leur utilisation
CH646412A5 (fr) Procede de preparation des produits hydrosolubles a base de (+)-catechine et compositions contenant ces produits.
LU83423A1 (fr) Pneumatique radial pour vehicules tout-terrain
FR2696740A1 (fr) Dérivés prodrogués de la diméthylbiguanide et applications comme médicaments.
FR2584405A1 (fr) Sels de furosemide, composition pharmaceutique les contenant et leur procede de preparation
FR2684382A1 (fr) Medicaments et preparations pures de dichlorhydrate de melarsomine, leur procede d'obtention et produits intermediaires obtenus.
LU83363A1 (fr) Compositions antitumeurs
BE887220A (fr) Compositions antitumeurs
BE1004051A4 (fr) Solution injectable et procede pour la preparer.
LU83081A1 (fr) Compositions antitumeurs
EP0092287B1 (fr) Sels d'acétylcystéine, leur préparation et leur utilisation
FR2471189A1 (fr) Procede de preparation d'un agent anti-tumoral comprenant un composant cellulaire de streptococcus pyogenes
CH664284A5 (en) Chloroquine medicaments without bitter taste - contain complex of chloroquine with copolymer of methacrylic] acid and methyl methacrylate]
FR2586532A1 (fr) Procede de preparation d'un extrait atomise de graines fraiches stabilisees de cola.
BE1001704A3 (fr) Compositions aqueuses contenant un derive de l'acide piperidinylcyclopentylheptenoique.
LU82965A1 (fr) Nouveaux sels d'addition d'acides du 4'-(9-acridinylamino)methanesulf-m-anisidide,leur procede de production et composition pharmaceutique les contenant
EP0449722B1 (fr) Nouveaux complexes de l'acide tiaprofénique ou de ses esters insolubles ou partiellement solubles avec les cyclodextrines ou leurs dérivés
FR2662360A1 (fr) Composes d'inclusion de nimesulide avec la cyclodextrine, procedes pour la preparation de ces composes et compositions pharmaceutiques a activite analgesique et anti-inflammatoire les contenant.
FR2741532A1 (fr) Nouvelles compositions pharmaceutiques a action antimigraineuse et leur mode de preparation
FR2624120A1 (fr) Nouveaux sels organogermaniques utiles comme medicaments notamment comme activateurs des osteoblastes
FR2491927A1 (fr) Derives de cephalexine solubles dans l'eau, et procede pour leur preparation
CA2022447A1 (fr) Forme galenique orale ameliorant la biodisponibilite
BE886413A (fr) Nouveaux sels d'addition d'acides du 4'-(9-acridinylamino) methanesulf-m-anisidide, leur procede de production et composition pharmaceutique les contenant
CH665634A5 (en) Stable soluble catechin complexes - with a double salt of L-lysine, for liver protection and digestive ulcers
EP0066934A1 (fr) Sels de nitrofurantoine, leur préparation et leur utilisation

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: BRISTOL-MYERS CY

Effective date: 19920131